维普中文期刊产品整合服务
100篇 您的检索式:作者名="He, HM"
    题名 作者 年代 出处 被引量
127-Ald-triterpenoid saponins from Adina rubella显示文摘Four new triterpenoid saponins were isolated from the roots of Adina rubella Hance. They were characterized as adinaic acid 3β-O-[α-L-rhamnopyranosyl(l→2)-β-D-glucopyranosyl(l→2)-β-D-glucurono-pyranoside-6-O-methyl ester]-28-O-β-D)-glucopyranoside, adinaic acid 3β-O-[α-L-rham-nopyranosyl(l→2)-β-D-glucopyranosyl(l→2)-β-D-glucuronopyranoside-6-O-butyl ester]-28-O-β-D-glu-copyranoside, adinaic acid 3β-O-[β-D-glucopyranosyl(l→2)-β-D-glucopyranosyl]-(28→1)-β-D-gluco-pyranosyl(l→6)-β-D-glucopyranosyl ester, 27-hydroxyursolic acid 3β-O-[α-L-rhamnopyranosyl (l→2)-β-O-glucopyranosyl(l→2)-β-D)-glucuronopyranoside-6-O-methyl ester]-28-O-β-D)-glucopyranoside. Their structures were elucidated by spectral methods, especially with the aid of 2D NMR techniques. Their complete assignments of the 1H and 13C NMR signals were carried out.Fan, GJ He, ZS Wu, HM Xu, JF 1997Chinese Journal of Chemistry1997,15,5:2
2Occurrence of antibiotics and antibiotic resistance genes in a sewage treatment plant and its ef?uent-receiving river 显示文摘Xu J Xu Y Wang HM Guo CS Qiu HY He Y Zhang Y Li XC Meng W 2015Chemosphere2015,119,:1
3Acute pancreatitis signals activation of apoptosis-associated and survival gencs in mice显示文摘Gomez G Lee Hm He Q 2001Exp-Biol Med2001,226,7:1
4Efficacy and safety of alirocumab as add- on therapy in high-cardiovascular- risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 rag): design and rationale of the ODYSSEY OPTIONS Studies显示文摘ROBINSON JG COLHOUN HM BAYS HE 2014Clin Cardiol2014,37,10:1
5TRPC3 channel contributes to nitric oxide release:significance during normoxia and hypoxia-reoxygenation显示文摘Huang JH He GW Xue HM 0,,03:1
6Dominances in finger arteries显示文摘Haerle M Hafner HM Schaller HE 2002J Hand Surg2002,27,:1
7Acute pancreatitis signal activation of apoptosis associated and survival genes in mice 显示文摘Gomez G Lee HM He Q 2001Exp Biol Med2001,226,7:1
8Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement显示文摘Gencchi M He HM Noiseux N 2006FASEB J2006,20,:1
9Initial CT findings in 753 patients with severe head injury: a report from the NIH Traumatic Coma Data Bank显示文摘Eisenberg HM Gary HE Aldrich EF 1990Neurosurgery1990,73,:1
10TRPC3 channel contributes to nitric oxide release:signi-ficance during normoxia and hypoxia-reoxygenation显示文摘Huang JH He GW Xue HM 0,,:1
11Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: animprovement method 显示文摘Xia MF Yan HM He WY 2012Obesity2012,20,2:1
12The impact of obesity on maternal morbidity and feto - infant outcomes among macro- somic infants显示文摘Salihu HM Weldeselasse HE Rao K 2011J Matern Fetal Neonatal Med2011,24,9:1
13TLR4 activation under lipotoxic conditions leads to synergistic macrophage cell death through a TRIF-dependent pathway 显示文摘Schilling JD Machkovech HM He L 2013J Immunol2013,190,3:1
14Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvas- tatin (20 or 40 nag) or rosuvastatin (10 or 20 mg): design and ratio- nale of the ODYSSEY OPTIONS Studies 显示文摘Robinson JG Colhoun HM Bays HE 2014Clin Cardiol2014,37,10:1
15Evidence supporting paracrinc hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement显示文摘Gnccchi M He HM Noiseux N 2006FASEB Jouranl2006,20,6:1
16Modulation by nucleotides of binding sites for glibenclamide in rat aorta and cardiac ventricular membranes显示文摘Zhu QL He HM Xiao WB 2001J Cardiovasc Pharmacol2001,37,:1
17Golgi biogenesis in Toxoplasma gondii显示文摘Pelletier L Stern CA Pypaert M Sheff D Ngo HM Roper N He CY Hu K Toomre D Coppens I Roos DS Joiner KA Warren G 2002Nature2002,418,6897:1
18Efficacy ami safety of a1irocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin(20 or 40 mg) or rosuvastatin( 10 or 20 mg) : design and rationale of the ODYSSEY OPtionS studies显示文摘Robinson JG Colhoun HM Bays HE et a1 2014Clin Cardiol2014,37,10:1
19The buecofacial wall of maxillary sinus: an anatomical consideration for sinus augmentatinn显示文摘Yang HM Bae HE Won SY 2009Clin Implant Dent Relat Res2009,11,1:1
20Standardized ultrasound hepatic/re- nal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method显示文摘Xia MF Yan HM He WY 2012Obosity (Silver Spring)2012,20,2:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费